Hao Ai
- Reproductive Medicine top 10%
-
- Chronic Lymphocytic Leukemia Research 8
-
- Acute Lymphoblastic Leukemia research 5
- Reproductive Biology and Fertility 4
-
- Acute Myeloid Leukemia Research 11
- Multiple Myeloma Research and Treatments 3
-
- Hematological disorders and diagnostics 5
-
- Lymphoma Diagnosis and Treatment 4
-
- Retinoids in leukemia and cellular processes 3
- Co-authors
- Haiying ZhangYun ZhangJiabin LiuNan LiCui LiLili LiuXin LiZhong‐Ze Fang
- Partner nations
- ChinaSouth Korea
In The Last Decade
Hao Ai
44 papers receiving 383 citations
Peers
Comparison fields: 5 of 73
- Reproductive Medicine 61
- Genetics 40
- Public Health, Environmental and Occupational Health 105
- Obstetrics and Gynecology 26
- Cancer Research 49
Countries citing papers authored by Hao Ai
This map shows the geographic impact of Hao Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Ai more than expected).
Fields of papers citing papers by Hao Ai
This network shows the impact of papers produced by Hao Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Ai. The network helps show where Hao Ai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hao Ai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 4 | |
| 6 | 2022 | 18 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 14 | |
| 9 | 2020 | 30 | |
| 10 | 2020 | 2 | |
| 11 | 2019 | 6 | |
| 12 | 2018 | 28 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 23 | |
| 15 | 2017 | 0 | |
| 16 | 2017 | 4 | |
| 17 | 2015 | 1 | |
| 18 | 2015 | 1 | |
| 19 | 2014 | 99 | |
| 20 | 2014 | 1 |
About Hao Ai
Hao Ai is a scholar working on Hematology, Genetics and Emergency Medicine, having authored 50 papers that have together received 387 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (8 papers), Hematological disorders and diagnostics (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Reproductive Biology and Fertility (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Retinoids in leukemia and cellular processes (3 papers). The work is most often cited by research in Reproductive Medicine (61 citations), Genetics (40 citations) and Public Health, Environmental and Occupational Health (105 citations). Hao Ai has collaborated with scholars based in China and South Korea. Frequent co-authors include Haiying Zhang, Yun Zhang, Jiabin Liu, Nan Li, Cui Li, Lili Liu, Yun Zhang, Xin Li, Zhong‐Ze Fang and Huihuan Luo. Their work appears in journals such as Molecules and Cells, Cancer Biomarkers, Frontiers in Immunology, Frontiers in Plant Science and Journal of Diabetes and its Complications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.